CME Group Inc. (CME) PT Raised to $147.00

CME Group Inc. (NASDAQ:CME) had its price target boosted by Royal Bank Of Canada from $135.00 to $147.00 in a research note released on Monday morning, MarketBeat Ratings reports. Royal Bank Of Canada currently has an outperform rating on the financial services provider’s stock.

Several other equities analysts also recently commented on the stock. Zacks Investment Research downgraded shares of CME Group from a hold rating to a sell rating in a research note on Tuesday, July 11th. Keefe, Bruyette & Woods restated a hold rating and issued a $127.00 price target on shares of CME Group in a research note on Friday, July 14th. BidaskClub downgraded shares of CME Group from a hold rating to a sell rating in a research note on Friday, July 28th. Citigroup Inc. initiated coverage on shares of CME Group in a research note on Wednesday, July 12th. They issued a buy rating and a $140.00 price target on the stock. Finally, Jefferies Group LLC restated a buy rating and issued a $128.00 price target on shares of CME Group in a research note on Monday, July 10th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the stock. CME Group has a consensus rating of Buy and an average target price of $138.89.

Shares of CME Group (CME) opened at 134.95 on Monday. The firm has a 50-day moving average of $133.41 and a 200 day moving average of $124.37. The firm has a market capitalization of $45.87 billion, a price-to-earnings ratio of 27.55 and a beta of 0.73. CME Group has a 52-week low of $98.95 and a 52-week high of $138.49.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The firm had revenue of $925.00 million for the quarter, compared to the consensus estimate of $931.05 million. During the same period in the previous year, the company earned $1.14 earnings per share. The company’s quarterly revenue was up 2.1% on a year-over-year basis. Analysts predict that CME Group will post $4.81 EPS for the current year.

TRADEMARK VIOLATION WARNING: “CME Group Inc. (CME) PT Raised to $147.00” was first reported by BBNS and is owned by of BBNS. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://baseballnewssource.com/markets/cme-group-inc-cme-pt-raised-to-147-00/1719909.html.

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 25th. Shareholders of record on Friday, September 8th were paid a dividend of $0.66 per share. The ex-dividend date was Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a yield of 1.96%. CME Group’s payout ratio is 53.99%.

In related news, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, October 11th. The shares were sold at an average price of $136.83, for a total value of $342,075.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Martin J. Gepsman sold 200 shares of the firm’s stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $126.14, for a total transaction of $25,228.00. Following the completion of the transaction, the director now owns 43,311 shares of the company’s stock, valued at approximately $5,463,249.54. The disclosure for this sale can be found here. Insiders have sold 49,594 shares of company stock worth $6,239,015 over the last quarter. Corporate insiders own 0.57% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Guardian Life Insurance Co. of America raised its holdings in CME Group by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,309 shares of the financial services provider’s stock valued at $156,000 after buying an additional 9 shares during the last quarter. Honkamp Krueger Financial Services Inc. raised its holdings in CME Group by 0.4% in the 2nd quarter. Honkamp Krueger Financial Services Inc. now owns 2,937 shares of the financial services provider’s stock valued at $368,000 after buying an additional 13 shares during the last quarter. Hudock Capital Group LLC raised its holdings in CME Group by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 3,890 shares of the financial services provider’s stock valued at $487,000 after buying an additional 20 shares during the last quarter. Whittier Trust Co. raised its holdings in CME Group by 2.6% in the 2nd quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after buying an additional 27 shares during the last quarter. Finally, Ropes Wealth Advisors LLC raised its holdings in CME Group by 0.4% in the 2nd quarter. Ropes Wealth Advisors LLC now owns 10,801 shares of the financial services provider’s stock valued at $1,353,000 after buying an additional 38 shares during the last quarter. Institutional investors and hedge funds own 82.62% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation


Leave a Reply

 
© 2006-2017 BBNS.